Last reviewed 2026-04-19 · How we verify

CRC01

Curocell Inc. · Phase 1 active Biologic

At a glance

Generic name	CRC01
Sponsor	Curocell Inc.
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) (PHASE1)
Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus (PHASE1, PHASE2)
DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01) (PHASE2)
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma Patients (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results